Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial

NCT00381888 Phase 2 COMPLETED Results posted

RATIONALE: Fondaparinux may help prevent blood clots from forming in patients who are undergoing surgery for gynecologic cancer. PURPOSE: This phase II trial is studying how well fondaparinux works in preventing blood clots in patients undergoing surgery for gynecologic cancer.

Details

Lead sponsor	Masonic Cancer Center, University of Minnesota
Phase	Phase 2
Status	COMPLETED
Enrolment	44
Start date	2007-01
Completion	2009-01

Conditions

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Sarcoma
• Thromboembolism
• Vaginal Cancer
• Vulvar Cancer

Interventions

• fondaparinux sodium

Primary outcomes

• Number of Patients With Venous Thromboembolism at Week 4 — Week 4 (Days 28-35)
  Venous thromboembolism is the formation of a blood clot (thrombus) inside a blood vessel, obstructing the flow of blood through the circulatory system.

Countries

United States